Qube Research & Technologies (QRT)
SGMT icon

Qube Research & Technologies (QRT)’s Sagimet Biosciences SGMT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$955K Buy
182,738
+71,389
+64% +$398K ﹤0.01% 2515
2025
Q4 		$659K Buy
111,349
+4,503
+4% +$32.4K ﹤0.01% 2714
2025
Q3 		$733K Buy
+106,846
New +$866K ﹤0.01% 2616
2025
Q2 		– Sell
-34,184
Closed -$111K – 3926
2025
Q1 		$111K Buy
34,184
+16,243
+91% +$68.1K ﹤0.01% 2989
2024
Q4 		$80.7K Buy
+17,941
New +$90.9K ﹤0.01% 3028
2024
Q1 		– Sell
-1,247
Closed -$6.76K – 4834
2023
Q4 		$6.76K Buy
+1,247
New +$5.88K ﹤0.01% 3669

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SGMT Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Sagimet Biosciences (SGMT) stake by 64% in Q1 2026, buying an estimated $398K and bringing the position to 182,738 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

Qube Research & Technologies (QRT) first reported a position in SGMT in Q4 2023 and has held it in 6 quarters since. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Qube Research & Technologies (QRT) held 182,738 shares of Sagimet Biosciences worth $955K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 71,389 Sagimet Biosciences shares in Q1 2026, an estimated $398K.
  • Sagimet Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2515 holding.
  • Qube Research & Technologies (QRT) first reported a position in Sagimet Biosciences in Q4 2023 and has held it in 6 quarters since.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.